Exparel 1.3% 20ML 10S
Ended Awarded Last action
- Contract number
- SPE2DR26FBTHQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,249
Award facts
- Contract value 100% obligated
- $10,249.04 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,249.04 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order, issued on December 29, 2025, is for EXPAREL 1.3% 20ML in quantities of 10 units. EXPAREL is a specialty surgical anesthetic product used in clinical settings to provide extended pain relief during and after surgical procedures. This award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The contract performance location is Park Ridge, Illinois, with an ultimate completion date of December 29, 2025.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to supply comprehensive pharmaceutical products to Department of Defense military healthcare facilities worldwide. The parent IDC, valued at $499,999,999 with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for branded and generic prescription medications, biologics, and medical consumables. DMS Pharmaceutical Group's extensive product portfolio and demonstrated performance across multiple therapeutic categories position it as a critical pharmaceutical supplier within the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FBTHQ?
SPE2DR26FBTHQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 29, 2025.
How much is contract SPE2DR26FBTHQ worth?
The government has obligated $10,249 on SPE2DR26FBTHQ.
Is contract SPE2DR26FBTHQ an order under another contract?
Yes. SPE2DR26FBTHQ is a delivery order under SPE2DR25D9628, an indefinite delivery contract.
Was contract SPE2DR26FBTHQ competed?
The extent of competition for SPE2DR26FBTHQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award